Auro Laboratories Limited manufactures Glibenclamide Sulfonylurea Antidiabetic Agent. Auro Laboratories Limited is an ISO 9001:2000 certified company. The Glibenclamide Sulfonylurea Antidiabetic Agent appears to lower the blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. With chronic administration in Type II diabetic patients, the blood glucose lowering effect persists despite a gradual decline in the insulin secretary response to the drug. The combination of glyburide and metformin may have a synergistic effect, since both agents act to improve glucose tolerance by different but complementary mechanisms.
